Abbott Laboratories Stock

Equities

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:01 2024-05-28 pm EDT 5-day change 1st Jan Change
102 USD -1.92% Intraday chart for Abbott Laboratories -0.98% -7.38%
Sales 2024 * 41.7B Sales 2025 * 44.75B Capitalization 181B
Net income 2024 * 5.96B Net income 2025 * 7.18B EV / Sales 2024 * 4.47 x
Net Debt 2024 * 5.47B Net cash position 2025 * 640M EV / Sales 2025 * 4.03 x
P/E ratio 2024 *
29.4 x
P/E ratio 2025 *
25.3 x
Employees 114,000
Yield 2024 *
2.12%
Yield 2025 *
2.27%
Free-Float 86.96%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.92%
1 week-0.98%
Current month-3.79%
1 month-5.19%
3 months-15.08%
6 months-0.11%
Current year-7.38%
More quotes
1 week
101.56
Extreme 101.56
104.91
1 month
101.56
Extreme 101.56
107.16
Current year
101.56
Extreme 101.56
121.64
1 year
89.67
Extreme 89.674
121.64
3 years
89.67
Extreme 89.674
142.60
5 years
61.61
Extreme 61.61
142.60
10 years
36.00
Extreme 36
142.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 14-12-31
Director of Finance/CFO 51 96-12-31
Chief Tech/Sci/R&D Officer - 89-12-31
Members of the board TitleAgeSince
Director/Board Member 69 17-02-15
Director/Board Member 63 17-06-28
Director/Board Member 65 11-12-08
More insiders
Date Price Change Volume
24-05-28 102 -1.92% 4,771,127
24-05-24 104 -0.27% 4,455,866
24-05-23 104.2 -0.56% 5,862,199
24-05-22 104.8 +1.81% 5,933,598
24-05-21 103 -0.24% 4,391,572

Delayed Quote Nyse, May 28, 2024 at 04:00 pm EDT

More quotes
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
102 USD
Average target price
125.7 USD
Spread / Average Target
+23.29%
Consensus